Open Access. Powered by Scholars. Published by Universities.®
Adolescent;; Adult;; Aged;; Combined Modality Therapy;; Female;; Follow-Up Studies;; Humans;; *Implosive Therapy;; Male;; Middle Aged;; Obsessive-Compulsive Disorder/diagnosis/psychology/*therapy;; Risperidone/adverse effects/*therapeutic use;; Serotonin Uptake Inhibitors/adverse effects/*therapeutic use;; United States;; Young Adult
Articles 1 - 1 of 1
Full-Text Articles in Medicine and Health Sciences
Six-Month Outcomes From A Randomized Trial Augmenting Serotonin Reuptake Inhibitors With Exposure And Response Prevention Or Risperidone In Adults With Obsessive-Compulsive Disorder, E. B. Foa, H. B. Simpson, D. Rosenfield, M. R. Liebowitz, S. P. Cahill, J. D. Huppert, J., Jr. Bender, C. P. Mclean, M. J. Maher, R. Campeas, C. G. Hahn, P. Imms, A. Pinto, M. B. Powers, C. I. Rodriguez, P. E. Van Meter, D. Vermes, M. T. Williams
Six-Month Outcomes From A Randomized Trial Augmenting Serotonin Reuptake Inhibitors With Exposure And Response Prevention Or Risperidone In Adults With Obsessive-Compulsive Disorder, E. B. Foa, H. B. Simpson, D. Rosenfield, M. R. Liebowitz, S. P. Cahill, J. D. Huppert, J., Jr. Bender, C. P. Mclean, M. J. Maher, R. Campeas, C. G. Hahn, P. Imms, A. Pinto, M. B. Powers, C. I. Rodriguez, P. E. Van Meter, D. Vermes, M. T. Williams
Journal Articles
OBJECTIVE: To compare outcomes after 6-month maintenance treatment of adults diagnosed with obsessive-compulsive disorder (OCD) based on DSM-IV criteria who responded to acute treatment with serotonin reuptake inhibitors (SRIs) augmented by exposure and response prevention (EX/RP) or risperidone. METHOD: A randomized trial was conducted at 2 academic sites from January 2007 through December 2012. In the acute phase, 100 patients on therapeutic SRI dose with at least moderate OCD severity were randomized to 8 weeks of EX/RP, risperidone, or pill placebo. Responders entered the 6-month maintenance phase, continuing the augmentation strategy they received acutely (n = 30 EX/RP, n = …